Plain-English translation of NCT07334964 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Carpal tunnel syndrome causes pain, numbness, and weakness in the hand due to a pinched nerve in the wrist. This study is testing whether a robotic arm can improve the accuracy and safety of ultrasound-guided corticosteroid injections into the carpal tunnel compared to the traditional method where a doctor holds the ultrasound probe manually. The goal is to see if this new technology makes the injection procedure more effective and comfortable for patients.
Currently, doctors perform these injections by holding an ultrasound probe in one hand while injecting with the other, which can be technically challenging and may affect accuracy. Researchers want to know whether a robotic arm that steadies the ultrasound probe and frees up both the doctor's hands might lead to better results and fewer complications.
You will receive a single ultrasound-guided corticosteroid injection into your carpal tunnel. Half of participants will receive the injection using the traditional manual method, and half will have it performed with a robotic arm holding the ultrasound probe. After the injection, you will have follow-up check-ins at 7 days, 28 days, and 3 months via phone call, video consultation, or in-person visit. During these follow-ups, you will complete brief questionnaires about your pain level and symptoms to help researchers understand how well the treatment worked.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
France
Sponsor
Centre Hospitalier Régional d'Orléans
Enrollment target
~21 participants
Started
November 2025
Primary completion
July 2026
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in July 2026.